Priyatham S Mettu

Professor Priyatham S Mettu is applying his expertise to address challenges in the field of ophthalmology, with a particular focus on vitreoretinal diseases. As an Assistant Professor at Duke University School of Medicine, he dedicates his research and clinical practice to advancing the understanding and treatment of diabetic retinopathy, age-related macular degeneration, and retinal vascular diseases. His work is pivotal in the development of innovative therapies and imaging technologies that aim to enhance patient care and outcomes. Dr. Mettu is deeply involved in clinical trials that explore new therapeutic avenues for macular diseases, striving to bring cutting-edge solutions from the laboratory to the clinic. His research is characterized by a commitment to integrating novel imaging techniques, which are instrumental in creating personalized treatment plans tailored to the unique needs of each patient. This approach not only improves the precision of diagnoses but also optimizes the effectiveness of interventions. Throughout his career, Dr. Mettu has been recognized for his outstanding contributions to ophthalmology. He is a recipient of the prestigious Heed Foundation Fellowship, which acknowledges his potential as a leader in the field. Additionally, he has been honored with the Isbey Award, reflecting his excellence in clinical care, ethics, and research. These accolades underscore his dedication to advancing both the scientific and ethical standards of his profession. In addition to his research and clinical responsibilities, Dr. Mettu is committed to mentoring the next generation of ophthalmologists and researchers. His passion for education and innovation is evident in his efforts to inspire and guide students and colleagues alike. Through his work, Dr. Mettu continues to make significant strides in the fight against retinal diseases, contributing to a future where vision loss is increasingly preventable and treatable.